D. Prieto-Alhambra

First name
D.
Last name
Prieto-Alhambra
Li, X., Burn, E., Duarte-Salles, T., Yin, C., Reich, C., Delmestri, A., et al. (2022). Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Bmj, 379, e071594. http://doi.org/10.1136/bmj-2022-071594
View
Pineda-Moncusí, M., El-Hussein, L., Delmestri, A., Cooper, C., Alireza, M., Libanati, C., et al. (2022). Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK. J Bone Miner Res. http://doi.org/10.1002/jbmr.4648
View
Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., et al. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419
View
Oda, T., Jödicke, A. M., Robinson, D. E., Delmestri, A., Keogh, R. H., & Prieto-Alhambra, D. (2022). Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the UK. J Bone Miner Res. http://doi.org/10.1002/jbmr.4573
View
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., et al. (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373
View
Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., . Y. Strauss, V., et al. (2021). Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England. Bmj Open, 11, e046712. http://doi.org/10.1136/bmjopen-2020-046712
View
Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., . Y. Strauss, V., et al. (2021). Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England. Bmj Open, 11, e046712. http://doi.org/10.1136/bmjopen-2020-046712
View
Khalid, S., Calderon-Larranaga, S., Sami, A., Hawley, S., Judge, A., Arden, N., et al. (2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1
View
Swain, S., Coupland, C., Strauss, V., Mallen, C., Kuo, C. F., Sarmanova, A., et al. (2022). Clustering of comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice Research Datalink study. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2021.12.013
View
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Kiran, A., de Vries, F., et al. (2011). Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum. http://doi.org/10.1002/art.30214
View